Hyperfine Inc
NASDAQ:HYPR
Intrinsic Value
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. [ Read More ]
The intrinsic value of one HYPR stock under the Base Case scenario is 0.59 USD. Compared to the current market price of 0.79 USD, Hyperfine Inc is Overvalued by 26%.
Valuation Backtest
Hyperfine Inc
Run backtest to discover the historical profit from buying and selling HYPR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Hyperfine Inc
Current Assets | 88.9m |
Cash & Short-Term Investments | 75.2m |
Receivables | 4.1m |
Other Current Assets | 9.6m |
Non-Current Assets | 5.3m |
PP&E | 3m |
Other Non-Current Assets | 2.3m |
Current Liabilities | 8.8m |
Accounts Payable | 1.2m |
Accrued Liabilities | 5.4m |
Other Current Liabilities | 2.1m |
Non-Current Liabilities | 1m |
Other Non-Current Liabilities | 1m |
Earnings Waterfall
Hyperfine Inc
Revenue
|
11m
USD
|
Cost of Revenue
|
-6.3m
USD
|
Gross Profit
|
4.8m
USD
|
Operating Expenses
|
-52.9m
USD
|
Operating Income
|
-48.1m
USD
|
Other Expenses
|
3.9m
USD
|
Net Income
|
-44.2m
USD
|
Free Cash Flow Analysis
Hyperfine Inc
HYPR Profitability Score
Profitability Due Diligence
Hyperfine Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Hyperfine Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
HYPR Solvency Score
Solvency Due Diligence
Hyperfine Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Hyperfine Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HYPR Price Targets Summary
Hyperfine Inc
According to Wall Street analysts, the average 1-year price target for HYPR is 1.33 USD with a low forecast of 1.01 USD and a high forecast of 1.68 USD.
Ownership
HYPR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
HYPR Price
Hyperfine Inc
Average Annual Return | -57.51% |
Standard Deviation of Annual Returns | 44.18% |
Max Drawdown | -94% |
Market Capitalization | 56.8m USD |
Shares Outstanding | 71 950 000 |
Percentage of Shares Shorted | 2.32% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 136 full-time employees. The company went IPO on 2021-01-27. The firm provides a Swoop system, which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop Portable Magnetic Resonance Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional MRI scanners. MRI is a medical imaging technique used in radiology to image the human body’s anatomy and physiological processes. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. The company designed its Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and Artificial intelligence (AI)-powered software services. Its hardware uses modern computational power and deep learning advances. Its software addresses the traditional ease-of-use and integration challenges often presented by specialized medical technologies.
Contact
IPO
Employees
Officers
The intrinsic value of one HYPR stock under the Base Case scenario is 0.59 USD.
Compared to the current market price of 0.79 USD, Hyperfine Inc is Overvalued by 26%.